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Carotenoids and apocarotenoids are unique molecules that can be used for 
various purposes such as colorants or health care. Their antioxidant and 
anticancer properties have brought much industrial demands and explain the 
increasing number of studies involved in their synthesis by microbial species. 
In this study, the oleaginous yeast Yarrowia lipolytica was used to 
produce carotenoids by the introduction of heterologous genes phytoene 
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desaturase (crtI) and lycopene cyclase/phytoene synthase (crtYB) from the red 
yeast Xanthophyllomyces dendrorhous, in multiple copies in the Y. lipolytica 
genome, mediated by CRISPR/Cas9 system. The carotenoid content was 
further improved by fine tuning of the cytoplasmic acetyl-CoA pool, 
involving the overexpression of endogenous and exogenous genes regulating 
the flux towards acetyl-CoA. This approach improved carotenoid content by 
1.63 folds. Further engineering was performed by pulling the acetyl-CoA out 
from the mitochondria; The IDP gene, encoding isocitrate dehydrogenase
involved in the TCA cycle, was down regulated by the CRISPRi system and 
the ACL gene, encoding ATP citrate lyase providing the cytosolic acetyl-CoA, 
was overexpressed. This resulted in as much as 2.63-fold increase in the 
carotenoid content. The final strain JHYB102 could produce as much as 1.54
mg/g DCW of ß-carotene and 0.17 mg/g DCW of lycopene from 20 g/L of 
glucose.
Moreover, additional heterologous genes, ß-carotene reductase (crtZ)
from Pantoea ananatis and carotenoid cleavage dioxygenase (CCD2) from 
Crocus sativus were introduced to produce zeaxanthin and crocetin, 
respectively. The final strain JHYB104 with increased acetyl-CoA flux could 
produce up to 0.874 mg/g DCW of zeaxanthin.
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Carotenoids are C40 compounds of natural colorants, which are diversely 
utilized and known for their antioxidant and anti-cancer activity. The two 
common carotenoids often studied are lycopene and ß-carotene, which are 
also found frequently in human diets. Lycopene is a red pigment found in 
tomatoes used in food and cosmetic industries, while ß-carotene is an orange 
pigment found in carrots, found commonly in health care industries [1]. The 
global market for carotenoids is currently at $1.5 billion in 2017, and is 
postulated to grow to $2.0 billion by 2022 [2]. Crocetin is a red C20
apocarotenoid found in crocus flower, which is recently in increasing 
demands for its positive physiological effects like anti-atherosclerotic and 
anti-depressant activities [3]. However, the current methods of producing 
carotenoids naturally are limited, as natural resources like tomatoes or carrots 
contain only small amounts of carotenoids and need long growth cycles.
Therefore, microbial biosynthesis of carotenoids and apocarotenoids is more
advantageous to meet the growing demands due to its feasibility, efficiency 
and safety. 
1.2. Production of carotenoids in Y. lipolytica
A promising candidate for such production strategy is Yarrowia lipolytica. The 
oleaginous yeast Y. lipolytica is a non-conventional GRAS (generally 
recognized as safe) microorganism that is receiving much attention in the 
metabolic engineering fields owing to its large precursor pool for industry-
level metabolic processes as well as its ability to withstand harsh 
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environments like low pH [4]. Y. lipolytica not only has a large acetyl-CoA 
pool but can also produce large lipid droplets that can hold large non-polar 
molecules like carotenoids. Recently, diverse genetic tools such as the 
CRISPR/Cas9 or multiple site integration system have been implemented for 
Y. lipolytica, enabling it to become a more feasible metabolic engineering 
platform.
Y. lipolytica does not produce carotenoids naturally but carries an 
innate mevalonate pathway that can produce up to farnesyl pyrophosphate, a 
precursor for carotenoid biosynthesis. Two heterologous enzymes, 
bifunctional lycopene cyclase/phytoene synthase and phytoene desaturase, are 
required for lycopene and ß-carotene production. Then, two additional 
enzymes, ß-carotene hydroxylase and carotenoid cleavage dioxygenase, are 
required to produce zeaxanthin and crocetin (Figure 1).
1.3. Previous approaches for carotenoid production in Y.
lipolytica
Many studies have been reported for the biosynthesis of carotenoids lycopene, 
ß-carotene, and zeaxanthin in a range of different hosts including Escherichia 
coli, Saccharomyces cerevisiae and Y. lipolytica, as summarized in Table 1. 
These studies usually focus on extensive pathway engineering, media 
composition optimization and disruption of competitive pathways. On the 
other hand, only one study has been reported for the production of crocetin by 
S. cerevisiae, which also focused on fine-tuning of essential heterologous 
enzymes and media optimization [3].
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Enlargement of the cytoplasmic acetyl-CoA pool is a promising 
strategy to increase the carotenoid content. This strategy has been used in 
variety of studies to increase the flux of different biosynthetic products like 
fatty acids, triacetic lactone, and squalene in Y. lipolytica, products which also 
use cytoplasmic acetyl-CoA as the main precursor [5, 6]. For example, the 
lipid productivity in Y. lipolytica increased by 3.1 folds after rewiring and 
engineering the acetyl-CoA pathway.
1.3. Objectives
In this study, a carotenoid-producing Y. lipolytica strain was constructed by 
multi-site rDNA integration of essential heterologous genes, mediated by 
CRISPR/Cas9. Moreover, various push and pull gene manipulations were 
performed to increase the cytoplasmic acetyl-CoA flux, by overexpressing 
both endogenous and exogenous genes as well as downregulating IDP, a gene
regulating acetyl-CoA in the TCA cycle, using the CRISPRi system (Figure 2). 
The genes beneficial in increasing the carotenoid content was integrated in 
multiple sites of the genome using NHEJ mediated integration, with the 
expression of KU70 gene responsible for the NHEJ repair system [7]. Lastly, 
zeaxanthin was produced for the first time reported in Y. lipolytica.
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Figure 1. Metabolic pathway for carotenoid production in Y. lipolytica
Cytoplasmic acetyl-CoA is utilized through the mevalonate pathway to produce GGPP. HMG-
CoA reductase (Hmg1) and geranylgeranyl diphosphate synthase (Ggs1) regulate the rate 
limiting steps in the pathway. Lycopene cyclase/phytoene synthase (CrtYB) and phytoene 
desaturase (CrtI) from X. dendrorhous convert two molecules of GGPP to one molecule of ß-
carotene. ß-carotene reductase (CrtZ) from P. ananatis and carotenoid cleavage dioxygenase 2 
(CCD2) with the addition of aldehyde dehydrogenase (ALD) reduce ß-carotene into two 
molecules of crocetin; IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate; 
GPP, geranyl pyrophosphate; FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl 
pyrophosphate; HMG-CoA, 3-hydroxy-3-methylglutaryl-CoA
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Figure 2. Metabolic pathway for cytoplasmic acetyl-CoA in Y. lipolytica.
Red arrows indicate steps involved in “push”ing while yellow arrows indicate “pull”ing 
cytoplasmic acetyl-CoA. Innately, pyruvate is converted to acetaldehyde through pyruvate 
decarboxylase (PDC), which is then converted to acetate by acetyldehyde dehydrogenase 
(ALD), and finally metabolized to cytoplasmic acetyl-CoA by acetyl-CoA synthetase (ACS). 
Cytoplasmic acetyl-CoA production can also be achieved by the introduction of foreign 
enzymes like acetyl dehydrogenase (MhpF and EutE) or pyruvate formate lyase from E. coli.
The cytoplasmic acetyl-CoA pool is also strengthened by carnitine O-acetyltransferase (Cat2) 
by S. cerevisiae. Isocitrate dehydrogenase (IDP) regulates the enzymatic conversion of 
isocitrate to α-ketoglutarate in the TCA cycle. ATP-citrate lyase (ACL) converts cytoplasmic 
citrate to acetyl-CoA and oxaloacetate (OAA)
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2.1. Strains and culture conditions
All strains used in this study are listed in Table 2. E. coli strain DH5α [F-
Φ80dlacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17 (rK
–, mK
+) phoA
supE44 λ– thi-1 gyrA96 relA1] was used for genetic manipulations. E. coli was 
cultured in Luria-Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast extract, 
and 10 g/L NaCl) supplemented with 50 µg/mL ampicillin. Y. lipolytica PO1g 
ku70∆ strain was used as a parental strain of all the engineered strains. The 
URA3 deletion mutant was constructed by using the CRISPR/Cas9-mediated 
genome editing system [16]. Cells were cotransformed with pCRISPRyl-
URA3gRNA plasmid, consisting of Cas9 gene and guide RNA (gRNA) 
targeted to URA3 gene, and a DNA template for URA3 deletion obtained by 
PCR. After confirmation of the URA3 deletion by PCR, pCRISPRyl-
URA3gRNA plasmid was removed by growing cells in YPD (10 g/L yeast 
extract, 20 g/L bacto-peptone, and 20 g/L glucose) medium overnight. TRP1 
and IDP were deleted through targeted nucleotide editing by pCRISPRyl-
nCas9-pmCDA1-UGI as was described previously with few modifications [17]
[18]. 
Yeast cells were cultured in YPD or in synthetic complete (SC) 
medium (6.7 g/L yeast nitrogen base without amino acids and 1.4 g/L amino 
acids dropout mixture lacking His, Trp, Leu, and Ura) supplemented with 
auxotrophic nutrients and/or hygromycin-B as needed. For shake flask 
fermentation, yeast cells harboring plasmids were pre-cultured in selective SC 
medium containing 20 g/L glucose and inoculated to OD600 of 0.5 in 10 mL of 
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selective SC medium containing 20 g/L glucose in 100 mL flask, and then 
cultured at 30 °C with shaking at 170 rpm. 
2.2. Plasmid construction
Plasmids and primers used in this study are described in Table 3 and Table 4.
The genes crtI and crtYB were PCR amplified from coex416-crtI and 
p414GPD-crtYB, respectively [19]. Native sequence of crtZ from Pantoea 
ananatis was synthesized by Mbiotech, Inc. (Hanam, South Korea). CCD2 
from Crocus sativus was codon optimized (Thermo Fisher Scientific, 
Waltham, MA, USA) and synthesized. PDC2, ALD5, ACS1, and KU70 were 
obtained from Y. lipolytica genome. eutE, mhpF, pflA, and pflB were obtained 
from Y. lipolytica genome. CAT2 was obtained from S. cerevisiae genome.
pUAS1B8-TEF-Cas9 plasmid was generated by Gibson cloning of LEU2-
PUAS1B8-TEF-Cas9-TCYC1 fragment from pCRISPRyl with Amp
R gene cassette 
amplified from pCRISPRyl. To generate single-gene-expression plasmids, 
PCR-amplified gene cassettes were cloned into pYL-LEU, pYL-URA using 
AscI and NotI sites resulting in pYL-LEU-PDC2, pYL-LEU-ku70, pYL-
URA-ACS1, and pYL-URA-ALD5. ORFs were cloned into pUAS1B8-TEF 
plasmids using AscI and NheI sites, pUAS1B8-TEF-eutE, pUAS1B8-TEF-
mhpF, pUAS1B8-TEF-pflA, pUAS1B8-TEF-crtZ and pUAS1B8-TEF-CCD2. 
For plasmid coexpYL-LEU-TEF-PDC2ALD5 harboring multiple genes 
the gene expression cassette (promoter-ORF-terminator) flanked by MauBI 
and NotI sites was obtained by PCR from the single-gene-expression vectors, 
and then cloned between the AscI and NotI sites of pYL-LEU-PDC2. For 
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coexpUAS1B8-TEF-pflA-pflB, coexpUAS1B8-TEF-CCD2-crtZ, the 
sequential gene expression cassettes were flanked by Bsp119I and PacI from 
the single-gene-expression vectors, and then cloned between the ClaI and 
PacI sites of coexpression plasmids.
For rDNA site integrations, two half DNA fragments of rDNA1 (672 
bp) and rDNA2 (630 bp) were PCR-amplified from Y. lipolytica genome and 
AmpR cassette was PCR-amplified from pCRISPRyl. The DNA fragment 
containing rDNA1, AmpR, and rDNA2 was generated by overlap PCR, and 
then cloned between the Bsp120I and PacI sites of pADHintDSN [20], 
resulting in rDNAintDSN. Gene-expression cassettes (PEXP1-crtI-TLIP2 and 
PTEF1-crtYB-TMIG1) obtained by overlap PCR were cloned between PacI and 
AscI sites of rDNAintDSN, resulting in rDNAintcrtI and rDNAintcrtYB, 
respectively. Additional gene expression cassettes (PGPD-GGS1-TMIG1 and 
PTEF1-tHMG1-TLIP2) also obtained by overlap PCR (ORF obtained from Y.
lipolytica genome) were digested by MauBI and NotI then cloned into AscI 
and NotI sites of rDNAintcrtI and rDNAintcrtYB vectors resulting in 
rDNAintcrtIGGS1 and rDNAintcrtYBtHMG1, respectively.
For NHEJ-mediated random integrations, gene fragments PDC2, 
eutE and crtZ were digested by and cloned into BamHI and XhoI sites of 
rDNAintcrtI. Additional gene cassettes (PEXP1-ALD5-TCYC1, PEXP1-ACS1-TLIP2,
PUAS1B8-TEF-CAT2-TCYC1, PUAS1B8-TEF-CCD2-TCYC1) or auxotrophic marker gene 
cassettes (PURA3-URA3-TURA3, PTRP1-TRP1-TTRP1 and PEXP1-hphMX-TLIP2) were 
PCR amplified from Y. lipolytica genome or corresponding vector and 
digested by MauBI and NotI and subsequently cloned into AscI and NotI sites 
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of appropriate plasmids to eventually create rDNAintPDC2ALD5ACS1URA3, 
rDNAinteutECat2TRP1 and rDNAintcrtZCCD2ALD5hphMX.
For URA3 deletion using the CRISPR/Cas9 system, plasmid 
pCRISPRyl was purchased from Addgene. For TRP1 and IDP deletion and 
downregulation using CRISPR/Cas9 system, pCRISPRyl-nCas9-pmCDA1-
UGI and pCRISPRyl-dCas9-Mxi1 vectors were constructed from pCRISPRyl. 
URA3, TRP1, IDP-targeting gRNA was designed by CRISPR-RGenTools 
(http://www.rgenome.net/), and inserted into pCRISPRyl with appropriate 
gene cassettes (Cas9 or dCas9-Mxi1 or nCas9-pmCDA1-UGI) by DpnI-








F- Φ80dlacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17 (rK
–, 
mK
+) phoA supE44 λ– thi-1 gyrA96 relA1
Y. lipolytica
PO1g MATa ura3-302::URA3, leu2-270,xpr2-332, axp-2 [21]
PO1g ku70∆ PO1g ku70∆::loxP [22]
PO1g 
ku70∆ura3∆
PO1g ku70∆, URA3∆ This study
JHYB100
Selected strain from rDNA integration of PEXP1-crtI-TLIP2-PGPD-GGS1-
TMIG1 and PTEF1-crtYB-TMIG1-PTEF1-tHMG1-TLIP2 into PO1g 
KU70∆URA3∆
This study
JHYB101 JHYB100, TRP1∆ This study
JHYB102
Selected strain from NHEJ-mediated random integration of PEXP1-




Selected strain from NHEJ-mediated random integration of PEXP1-eutE-
TLIP2-PUAS1B8-TEF-CAT2-TCYC2 using TRP1 in JHYB102
This study
JHYB104
Selected strain from NHEJ-mediated random integration of PEXP1-crtZ-




Table 3. Primer sequences used in this study.
Primers Sequence (5’-3’)

































































































Table 4. Plasmids used in this study.
Plasmid Description Reference
pIMR53-AUX URA3, ARS18, AmpR [23]
pIMR53-AUX-EXP1 pIMR53-AUX, PEXP1, TCYC1 This study
pIMR53-crtI-crtYB
pIMR53-AUX-EXP1 with the sequential 




tRNAGly-gRNA, LEU2, CEN, Ori1001, 
AmpR, ColE1
[16]
pCRISPRyl-URA3 pCRISPRyl incorporating URA3 gRNA This study
pCRISPRyl-rDNA pCRISPRyl incorporating rDNA gRNA This study
pCRISPRyl-dCas9-Mxi1





pCRISPRyl replacing CAS9 with dCAS9-




pCRISPRyl replacing CAS9 with dCAS9-




pCRISPRyl replacing CAS9 with dCAS9-




pCRISPRyl replacing CAS9 with dCAS9-




pCRISPRyl replacing CAS9 with dCAS9-




pCRISPRyl replacing CAS9 with nCAS9-





pCRISPRyl replacing CAS9 with nCAS9-






























pUAS1B8-TEF-Cas9 replacing CAS9 with 
pflA
This study













pUAS1B8-TEF-CCD2 with the insertion 
of PUAS1B8-TEF(136)-crtZ-TCYC1 This study
pYL-LEU




URA3, CEN, Ori1001, AmpR with AscI, 
NotI enzyme sites
This study
pYL-LEU-KU70 pYL-LEU with the insertion of PKU70-
KU70-TKU70 This study
pYL-LEU-PDC2

































rDNAintcrtYB with the insertion of PTEF1-
tHMG1-TLIP2
This study
rDNAintPDC2 rDNAintcrtI replacing crtI with PDC2 This study
rDNAintPDC2-ALD5-
ACS1-URA3
rDNAintPDC2 with the sequential 
insertion of PEXP1-ALD5-TCYC1, PEXP1-
ACS1-TLIP2, URA3
This study
rDNAinteutE rDNAintcrtI replacing crtI with eutE This study
rDNAinteutECat2TRP1
rDNAinteutE with the sequential insertion 
of PUAS1B8-TEF(136)-CAT2-TCYC1, TRP1
This study
rDNAintcrtZ rDNAintcrtI replacing crtI with crtZ This study
rDNAintcrtZCCD2ALD5
hphMX





2.3. rDNA-integration and NHEJ-mediated random 
integration
The rDNA integrated strain was constructed by CRISPR/Cas9-mediated 
genome editing system. Cells were cotransformed with pCRISRPyl-rDNA
plasmid and rDNA integrative vector linearized by SwaI. To construct the 
NHEJ-mediated randomly integrated strains, JHYB101 cells were first 
transformed with pYL-LEU-KU70. A transformant was cultured overnight in 
SC-Leu medium with 20 g/L glucose in 30 °C with shaking at 170 rpm. After 
24 h, the cells were harvested (O.D.600=3) and transformed with rDNA 
integrative vector with genes of interest, linearized by I-PpoI and NotI. The 
strains were screened by color and selected in SC medium supplemented with 
auxotrophic nutrients as needed and 20 g/L of glucose.
2.4. Quantitative PCR (qPCR)
To determine the copy numbers of the genome-integrated genes, GGS1 and 
HMG1, qPCR was performed with gene-specific primers and 1xSYBR Green 
I master mix (Roche Applied Science). qPCR was performed with 45 cycles 
of 95°C for 40 s, 60°C for 20 s, and 72°C for 20 s on a LightCycler 480 II 
System (Roche Applied Science). The ACT1 gene was used as a reference 
control. The crossing point (Cp) values were processed using LightCycler 
Software version 1.5 (Roche Applied Science) and expression levels were 




Cell growth was determined by the measurement of an optical density at 600 
(OD600) with spectrophotometer (Varian Cary® 50 UV-Vis). To determine the 
concentrations of glucose and other secondary metabolites 500 μL of culture 
supernatants filtered through a 0.22 μm syringe filter were analyzed by High 
performance liquid chromatography (HPLC) as previously described [24]. 
Carotenoids were extracted with the customized hot-HCl method from the 
cultured cells [25]. Same amounts of cultured cells were used for dry cell 
weight measurement. The sampled cells were resuspended in 3N HCl and 
broken by boiling for 10 min. After cooling in ice for 10 min, the broken cells 
were washed with water and collected by centrifugation for 1 min. An 
appropriate volume of HPLC grade acetone was added and vortexed for 5 min. 
The cell debris was removed by centrifugation for 1 min. The supernatant was 
used for the analysis of carotenoids. Carotenoids were quantitated by 
Surveyor Plus HPLC system (Thermo Fisher Scientific) with Agilent Eclipse 
XDB-C18 column (5 μm, 4.6 x 250 mm) using a standard curve generated 
with lycopene, ß-carotene and zeaxanthin obtained from Sigma Aldrich. 
Analysis was performed with methanol: dichloromethane: acetonitrile 
(42:16:42) as a mobile phase at a flow rate of 1.2 mL/min and Surveyor PDA 
Detector at 450 nm. The column temperature was maintained at room 
temperature. Standard crocetin was purchased from CoreScience Korea. 
Crocetin analysis was performed with the same column with methanol:water 







3.1. Construction of ß-carotene biosynthetic pathway in Y. 
lipolytica
To produce carotenoids in Y. lipolytica, heterologous ß-carotene biosynthetic 
pathway genes from carotenoid-producing red yeast X. dendrorhous, 
consisting of genes encoding phytoene desaturase (crtI) and bifunctional 
lycopene cyclase and phytoene synthase (crtYB) were introduced into Y. 
lipolytica strain PO1g ku70∆ ura3∆ (Figure 1). The two ß-carotene producing 
genes were expressed under the control of PEXP1 promoter by using ARS-based 
low copy plasmid based on pIMR53-AUX. Y. lipolytica harboring pIMR53-
AUX-crtI-crYB produced a trace amount of ß-carotene, as validated by the 
yellow color when compared to the control strain. However, the amount of ß-
carotene produced here was too low to be determined by HPLC (data not 
shown). On the other hand, the control strain harboring empty pIMR53-AUX 
plasmid maintained a white color, confirming that the biosynthetic genes from 
X. dendrorhous are functional in producing ß-carotene in Y. lipolytica. 
3.2. Construction of a carotenoid-producing Y. lipolytica
strain by rDNA integration of biosynthetic genes
For a more efficient and stable production of carotenoids, ß-carotene 
biosynthetic genes were integrated into the chromosome. Homologous 
recombination using these rDNA sites allows random multiple copy 
integration of target genes. Therefore, to improve ß-carotene production, we 
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integrated the two ß-carotene biosynthetic genes together with the native 
genes, GGS1 and truncated HMG1 (tHMG1), which regulate the rate-limiting 
steps in the mevalonate pathway [26]. For a marker-less integration, 
CRISPR/Cas9 system was implemented to target the rDNA sequence. Two 
rDNA-integration cassettes containing either crtI and GGS1 genes or crtYB 
and tHMG1 genes were transformed together with the rDNA targeting 
plasmid pCRISPRyl-rDNA into Y. lipolytica PO1g ku70∆ ura3∆, and the 
transformants were selected based on orange color in SC-Leu medium. Strain 
JHYB100 with the strongest color was selected for further engineering 
experiments. The copy numbers of the integrated genes were determined by 
qPCR. Results indicated that JHYB100 genome contains 2 copies of crtI and 
GGS1 and 3 copies of crtYB and tHMG1 (Figure 3B). JHYB100 alone could 
produce around 0.84 mg/g DCW carotenoids consisting of lycopene and ß-
carotene. TRP1 from JHYB100 was deleted to generate JHYB101 for use as 
an additional auxotrophic marker.
24
Figure 3. Construction of ß-carotene producing strain by rDNA integration of X. 
dendrorhous genes.
(A) Schematic illustration of the procedure of rDNA integration of X. dendrorhous genes into Y. 
lipolytica. rDNA sequence was targeted by CRISPR-Cas9 method and the rDNA integrative 
vector was linearized and transformed into Y. lipolytica. The colonies with integrated genes 
were screened and selected based on orange color. (B) Copy numbers of the integrated genes in 
the selected strain was analyzed qPCR. Each value indicates the average ± SD of duplicate 
experiments.
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3.3. “Push” strategy of cytoplasmic acetyl-CoA flux to 
improve carotenoid production
Although multiple integration of biosynthetic genes demonstrated an 
improvement in the production of carotenoids, the production levels were still 
low, which might be due to a limited pool of cytoplasmic acetyl-CoA, the first 
precursor of carotenoids. Consequently, multiple genes were overexpressed to 
enlarge the acetyl-CoA pool and their corresponding effects on total 
carotenoid levels were observed. 
Three native genes, PDC2, ALD5, and ACS1, were overexpressed 
and four genes that allow for alternative pathways to cytoplasmic acetyl-CoA, 
including CAT2 from S. cerevisiae, mhpF, eutE, and pflA-pflB from E. coli
(Figure 2) were introduced by constitutive expression plasmids. The 
overexpression of endogenous genes mentioned above has successfully 
improved the production of triacetic acid lactone in Y. lipolytica [6], while the 
expression of exogenous genes from other microbial species has increased 
lipid production [5], of which both metabolites require acetyl-CoA as the 
main precursor. The five gene sets were expressed under the control of strong 
constitutive promoter PUAS1B8-TEF by expression plasmids. All five gene sets, 
excluding pflA-pflB, showed improvements in carotenoid levels (Figure 4A), 
which suggests that the expression and overexpression of exogenous and 
endogenous pathways were helpful in pushing the acetyl-CoA flux and hence 
allowing for a larger availability of precursor pool for carotenoid synthesis. 
Among the tested genes, CAT2 showed the highest improvement in carotenoid 
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production, increasing it by 1.27 fold. The two genes both encoding 
acetaldehyde dehydrogenase, mhpF and eutE showed similar increase in 
carotenoid level. 
To assess the effect of overexpressing multiple exogenous genes that 
up-regulate the acetyl-CoA flux, mhpF, eutE, and pflA-pflB were 
overexpressed together with CAT2, which showed the largest improvement in 
carotenoid level. Simultaneous expression of CAT2 and eutE showed the 
maximum carotenoid level (1.04 mg/g DCW) but the level was not largely 
different to the expression of CAT2 alone (Figure 4B). This result may be 
because of epistatic characteristics of genes which does not always allow for a 
synergistic effect [27].
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Figure 4. Effects of the overexpression of native and foreign genes involved in 
cytoplasmic acetyl-CoA pool on carotenoid production.
(A) JHYB101 harboring an empty vector and harboring pUAS1B8-TEF vectors with indicated 
genes (B) JHYB101 harboring an empty vector and JHYB101 harboring coexpUAS1B8-TEF 
vectors with indicated genes in combination with CAT2 were grown in SC-Leu, Ura medium 
containing 20 g/L glucose for 120 h and ß-carotene production was measured. Each value 
indicates the average ± SD of triplicate experiments.
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3.4. “Pull” strategy of mitochondrial acetyl-CoA flux out 
to the cytoplasm
An alternative approach to increase the cytoplasmic acetyl-CoA flux available 
for carotenoid production is to “pull” the acetyl-CoA occupied in the 
mitochondria via the TCA cycle out to the cytoplasm. Hence, downregulation 
of NADP+-dependent isocitrate dehydrogenase (IDP) was performed. This 
may lead to citrate accumulation followed by cytosolic transport, which pulls 
out the acetyl-CoA to the cytoplasm. This approach can impose a similar 
effect as to when yeast cells are under nitrogen depletion [28] and hence result 
in amount increase of secondary metabolites like lipid or carotenoids.
Downregulation of IDP was mediated by the CRISPRi system [29]. 
Plasmid pCRISPRyl-dCas9 fused with a Mxi1 repressor was constructed for 
the targeting and transcriptional repression of the promoter of IDP. Five sites 
of the promoter region within 300 bp of the ORF of IDP were randomly 
selected as the gRNA target sites as illustrated (Figure 5A). The repression of 
IDP showed a significant improvement in carotenoid production in the strain 
JHYB101. With the expression of pCRISPRyl-dCas9-Mxi1-IDP(2), the 
carotenoid biosynthesis improved as much as 2.63 folds with carotenoid 
content reaching up to 1.81 mg/g DCW (Figure 5B). This suggests that much 
of acetyl-CoA concentration is occupied in the TCA cycle, and pulling it out 
of the mitochondria is indeed successful in increasing the flux toward the 
cytoplasm, improving the carotenoid concentration in return. Furthermore, the 
cell growth was not hindered when IDP was downregulated (Figure 5B), 
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which also indicates that this approach of increasing the flux of secondary 
metabolites in Y. lipolytica may be applicable for various industrial purposes. 
To confirm the effects of IDP downregulation, IDP gene was deleted and the 
results were compared to the strain harboring dCas9-Mxi1-IDP(2), which 
showed the best result in increasing carotenoid flux. Results showed that its 
deletion showed similar effects to IDP downregulation, with downregulation 
showing slightly better results (Figure 5C).
An additional method to pull the cytoplasmic acetyl CoA flux out 
from the mitochondria is to overexpress ATP citrate-lyase (ACL) gene, which 
mediates the conversion of citrate in the cytosol to acetyl-CoA and 
oxaloacetate. Citrate accumulated in the mitochondria, especially upon 
inactivation of Idp, can be transported into the cytoplasm, serving as a source 
of the cytoplasmic acetyl-CoA. Subsequently, ACL1 and ACL2 were 
overexpressed by a plasmid in JHYB101, of which the overexpression of 
ACL1 and ACL2 together increased the carotenoid content by 1.35 fold
(Figure 6). 
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Figure 5. Effects of “pull” of acetyl-CoA from mitochondria to the cytoplasm on 
carotenoid production.
(A) Schematic illustration of downregulation of PIDP mediated by CRISPRi. Five sites on the 
promoter sequence (within 300 bp) of IDP were randomly selected as the sgRNA target sites. 
Downregulation was mediated by pCRISPRyl-dCas9-Mxi1. (B) JHYB101 harboring 
pCRISPRyl-dCas9-Mxi1 and JHYB101 harboring pCRISPRyl-dCas9-Mxi1 targeting five 
different sits on PIDP (numbered 1 through 5) were grown in SC-Leu medium containing 20 g/L 
glucose for 96 h and their carotenoid production levels and O.D.600 were measured. (C) 
JHYB101 harboring pCRISPRyl-dCas9-Mxi1, JHYB101 harboring pCRISPRyl-dCas9-Mxi1-
IDP(2) and JHYB106 were grown in SC-Leu medium containing 20 g/L glucose for 120 h and 
their carotenoid production levels and O.D.600 were measured. Each value indicates the average 
± SD of triplicate experiments.
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Figure 6. Effects of overexpression of ACL on carotenoid production.
JHYB101 harboring empty vector and pUAS1B8-TEF expressing the indicated genes (ACL1, 
ACL2 or ACL1 and ACL2) were grown in SC-Leu medium containing 20 g/L glucose for 120 h 
and their carotenoid production levels were measured. Each value indicates the average ± SD of 
triplicate experiments.
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3.5. Production of further carotenoids, zeaxanthin and 
crocetin
After establishing a strain (JHYB101) that stably produces ß-carotene, this 
strain was further engineered to produce the next carotenoid metabolites, 
zeaxanthin and crocetin, which are carotenoids that have not yet been reported 
to be produced in Y. lipolytica. The crtZ gene from P. ananatis, encoding ß-
carotene hydroxylase, was expressed under a constitutive promoter on a 
plasmid. HPLC result confirmed the production of zeaxanthin in the strain 
JHYB101, reaching a content of 70.3 µg/g DCW (Figure 7).
To produce crocetin, three enzymes, CrtZ, CCD2 and ALD, need to 
be expressed. When all three genes were expressed simultaneously, the cell 
color turned red, indicating the color of crocetin, while other flasks remained 
orange or yellow, indicating the color of ß-carotene or zeaxanthin (data not 
shown). However, the amount of crocetin could not be measured due to the 
low concentration. 
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Figure 7. Zeaxanthin production by JHYB101.
(A) JHYB101 harboring empty vector and JHYB101 harboring pUAS1B8-TEF-crtZ were 
grown in SC-Leu medium containing 20 g/L glucose for 120 h and their carotenoid production 
levels were measured. Each value indicates the average ± SD of triplicate experiments. (B) 
HPLC spectra of carotenoids for cell extracts of JHYB101 harboring an empty vector and 
JHYB101 harboring pUAS1B8-TEF-crtZ vector.
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3.6. Integration of beneficial genes for optimal production 
of carotenoids
To increase the flux of acetyl-CoA and stably produce carotenoids, several 
genes were sequentially integrated into the genome. The random integration 
method was selected for an increase in chances of multiple copy integration. 
The platform strain JHYB101 has its gene KU70 deleted. In order to facilitate 
random integration by non-homologous end joining, KU70 had to be 
expressed (data not shown). Therefore, before every occasion of random 
integration, pYL-LEU-ku70 was transformed into the strain of interest. The 
transformant was incubated in SC-Leu medium for 24 h before the subsequent 
transformation of integrative gene cassette.
To construct a strain that optimally and natively produces 
carotenoids by enlarging the endogenous acetyl-CoA flux in Y. lipolytica, the 
gene cassette PDC2-ALD5-ACS1 was integrated into the chromosome by 
NHEJ-mediated random integration using the URA3 auxotrophic marker. 
Among 16 strains tested, the strain with the largest carotenoid level
(JHYB102) was able to produce 1.71 mg/g DCW of carotenoids, which is 
1.63 fold of that of JHYB101 (Figure 8). 
Next, CAT2-eutE gene cassette, which showed the largest 
improvement of carotenoids by plasmid, was additionally integrated by 
random integration using the TRP1 auxotrophic marker. However, this did not 
result in an increase in an increase in carotenoid level, which is thought to be 
due to epistatic characteristics of the genes (data not shown).
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Figure 8. Effect of additional integration of PDC2-ALD5-ACS1 on carotenoid 
production.
16 transformants of PDC2-ALD5-ACS1 integration into JHYB101 by URA3 were randomly 
selected, grown in SC-Leu medium containing 20 g/L glucose for 120 h and their carotenoid 
production levels were measured. Each value indicates the average ± SD of duplicate 
experiments.
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Lastly, in an effort to increase the concentration and pool of 
zeaxanthin, the gene cassette containing crtZ, CCD2, and ALD was integrated 
into the genome by hygromycin-B selection. Among 6 colonies tested, the 
colony with the largest improvement could reach up to 3.50 mg/L in titer and 
87.4 µg/g DCW in content of zeaxanthin (Figure 9). Yet, this content was too 
low to allow for flux toward crocetin. 
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Figure 9. Zeaxanthin production levels after integration of crtZ-CCD2-ALD on 
JHYB102.
6 transformants were selected and tested for zeaxanthin production after random integration of 
crtZ-CCD2-ALD using hygromycin-B marker. Each colony’s titer (mg/L) and content (µg/g 
DCW) were measured. Cells were grown in SC-Leu medium containing 20 g/L glucose for 120 








Carotenoids and apocarotenoids, namely lycopene, ß-carotene, zeaxanthin and 
crocetin, are chemicals in increasing demands for their colorant and 
antioxidant functions, which can also serve as anticancer agents. They are 
frequently found in forms of health supplements, cosmetics and animal feeds.
However, due to the limited production size and rate of carotenoids from 
natural resources, a large number studies have focused on producing 
carotenoids from microbial species including bacteria and yeasts, which 
allows for a more affordable and efficient production of carotenoids.
The oleaginous yeast Y. lipolytica does not naturally produce 
carotenoids. However, it holds an advantage owing to its large acetyl-CoA 
pool, the main precursor molecule for carotenoids. Also, the innate 
mevalonate pathway exists in Y. lipolytica producing up to GGPP. This allows 
for Y. lipolytica to have a better tolerance to products in the mevalonate 
pathway like FPP and GGPP, and environmental stress like pH. Y. lipolytica
has previously proven its capability of producing large amounts of carotenoids 
and is increasingly being used as the platform for metabolic engineering of a 
variety of bioproducts, which also uses Acetyl-CoA as the precursor molecule. 
In this study, we were able to efficiently produce ß-carotene and up to 
zeaxanthin, for the first time reported, from Y. lipolytica using various
strategies to enlarge the acetyl-CoA precursor pool. 
Two heterologous genes crtI and crtYB from X. dendrorhous were 
introduced, together with two native genes tHMG1 and GGS1, into the Y. 
lipolytica genome. This step was successfully performed by the integration 
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into rDNA sites, which exist in multiple copies in Y. lipolytica, mediated 
marker-less by the CRISPR/Cas9 system. The subsequent strain JHYB100 
could around 0.84 mg/g DCW of lycopene and ß-carotene. The marker gene 
TRP1 was deleted from JHYB100 to generate JHYB101.
The acetyl-CoA pool was strengthened by the introduction of native 
genes PDC2, ALD5 and ACS1, which are responsible for the flux from 
pyruvate to cytoplasmic acetyl-CoA in Y. lipolytica. Random integration using
the URA3 marker was performed in JHYB101 by pre-expression of KU70 to 
encourage the NHEJ repair system. From many candidates, the strain with the 
best performance in carotenoid production, JHYB102, was chosen with a 
1.63-fold improvement (1.71 mg/g DCW) in carotenoid production than 
JHYB101. Then, heterologous genes CAT2 from S. cerevisiae and eutE from 
E. coli, which also act by “pushing” the flux toward cytoplasmic acetyl-CoA 
were integrated into the genome by random integration using the TRP1 
marker, but this step did not result in a positive outcome.
To pull the acetyl-CoA out from mitochondria to the cytoplasm, the 
gene IDP was downregulated by using the CRISPRi system targeting the 
promoter regions of IDP. This strategy largely improved the carotenoid 
production in JHYB101 as much as 2.63 folds, resulting in 1.81 mg/g DCW 
of carotenoids. Deletion of IDP showed a similar effect in carotenoid 
production levels. Additionally, ACL1 and ACL2 were overexpressed, 
increasing the carotenoid production by 1.35 fold.
Additional genes, crtZ from P. ananatis was introduced into the Y. 
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lipolytica genome to produce crocetin by random integration using the 
hygromycin-B resistance marker. The strain JHYB104, with integrated crtZ,
could successfully produce up to 0.874 mg/g DCW zeaxanthin.
This study focused on improving carotenoid production by a push 
and pull strategy to increase the cytoplasmic acetyl-CoA pool and producing 
crocetin for the first time in Y. lipolytica. This work showed that a significant 
amount of acetyl-CoA in Y. lipolytica is occupied in the mitochondria by the 
TCA cycle and this approach is useful in improving the bio-production 
efficiency of cytoplasmic acetyl-CoA-derived chemicals. Hence, we expect 
this study approach to become a basic platform not just for metabolic 
engineering of carotenoids but for numerous acetyl-CoA-derived products in Y. 
lipolytica.
Further genetic manipulations remaining will be downregulating IDP 
in JHYB103 as well as overexpressing ACL. Also, more efforts shall be made 
to increase the zeaxanthin pool to allow for crocetin biosynthesis.
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국문 초록
카로티노이드 및 아포카로티노이드는 는 이소프레노이드 계열 물질
로 항산화 및 발암 억제 작용 기능을 위해 상업적으로 사용되어 각
광받고 있다. 현재까지 카로티노이드의 제한적인 정제 방법과 생산
방법은 대사공학적 접근을 통한 대량생산의 연구로 극복되고 있으
며, 해당 방법을 통한 수요는 증가하고 있는 추세이다. 
본 연구에서는 유지 효모로 분류되는 Y. lipolyitca의 유전체에
rDNA 위치에 X. dendrorhous의 phytoene desaturase 와 phytoene 
synthase/lycopene cyclase를 암호화 하는 두가지 유전자 crtI와 crtYB를
CRISPR/Cas9 시스템을 통해 도입함으로써 ß-carotene을 생산하는 균
주를 제작하였다. 또한 카로티노이드의 전구체 물질로 작용하는
acetyl-CoA의 양을 증가시키고자 acetyl-CoA 생산에 관여하는 유전자
들을 과발현하였고, 이를 통해 균주 내에에 카로티노이드 양을 약
1.63배 증가할 수 있었다. 또한, 미토콘드리아 내에 존재하는 acetyl-
CoA를 세포질로 이동시키고자 CRISPRi 시스템을 통해 TCA cycle에
관여하는 유전자인 IDP를 억제하고, citrate로부터 acetyl-CoA를 생산
하는 ACL 유전자를 과발현 하였을 때 카로티노이드 양이 최대 2.63
배 증가하였다. 최종 균주를 통해 20 g/L의 포도당으로부터 1.54
mg/g DCW의 ß-carotene과 0.170 mg/g DCW의 lycopene을 생산하였다.
마지막으로, P. ananatis에서 유래된 ß-carotene reductase (crtZ) 
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유전자와 C. sativus에서 유래한 carotenoid cleavage dioxygenase 유전자
를 추가적으로 Y. lipolytica 내로 도입함으로써 zeaxanthin까지 생산하
는 최초의 Y. lipolytica 균주를 얻었다. 최종 균주는 20 g/L의 포도당
을 사용해 0.874 mg/g DCW의 zeaxanthin을 생산하였다.
주요어 : 대사공학, 카로티노이드, Yarrowia lipolytica, rDNA, 
CRISPR/Cas9, CRISPRi
학 번 : 2017-24688
